Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Elaeocarpus decipiens Hemsl. Chloroplast genome sequencing

PROVIDER: PRJNA731248 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14597167_1.fastq.gz	Fastqsanger.gz
	SRR14597167_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Project description:Pterolobium punctatum Hemsl Chloroplast genome sequencing

| PRJNA876053 | ENA

Project description:The complete chloroplast genome of Elaeocarpus sylvestris

| PRJNA691090 | ENA

Project description:Chloroplast genome of Fissistigma oldhami (Hemsl.) Merr.

| PRJNA688316 | ENA

Project description:The complete chloroplast genome sequence of Elaeocarpus Duclouxii

| PRJNA1103375 | ENA

Project description:The complete chloroplast genome of Lonicera similis Hemsl.

| PRJNA758746 | ENA

Project description:The complete chloroplast genome of Viburnum carlesii Hemsl

| PRJNA746408 | ENA

Project description:Genome sequencing of Elaeocarpus petiolatus

| PRJNA1173526 | ENA

Dual Roles for CND1 in Maintenances of Nuclear and Chloroplast Genome Stability in Plants [ChIP-seq]

Project description:The coordination of chloroplast and nuclear genome status are critical for plant cell function, but the mechanism remain largely unclear. In this study, we report that Arabidopsis thaliana CHLOROPLAST AND NUCLEUS DUAL-LOCALIZED PROTEIN 1 (CND1) maintains genome stability in both the chloroplast and the nucleus.

2022-12-13 | GSE220489 | GEO

Bothriochloa decipiens

Project description:Bothriochloa decipiens Genome sequencing

| PRJNA814342 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data